Non-severe SARS-CoV-2 infection is characterised by very early T cell proliferation independent of type 1 interferon responses and distinct from other acute respiratory viruses
Aneesh Chandran, Joshua Rosenheim, Gayathrie Nageswaran, Leo Swaddling, Gabriele Pollara, Rishi K Gupta, Jose Afonso Guerra-Assuncao, Annemarie Woolston, Tahel Ronel, Corrina Pade, Joseph Gibbons, Blanca Sanz-Magallon Duque De Estrada, Marc Robert de Massy, Matthew Whelan, Amanda Semper, Tim Brooks, Daniel M Altmann, Rosemary J Boyton, Áine McKnight, Charlotte Manisty, Thomas Alexander Treibel, James Moon, Gillian S Tomlinson, Mala K Maini, Benjamin M Chain, Mahdad Noursadeghi, COVIDsortium Investigators
doi: https://doi.org/10.1101/2021.03.30.21254540
Aneesh Chandran
1Division of Infection and Immunity, University College London, London, UK
Joshua Rosenheim
1Division of Infection and Immunity, University College London, London, UK
Gayathrie Nageswaran
1Division of Infection and Immunity, University College London, London, UK
Leo Swaddling
1Division of Infection and Immunity, University College London, London, UK
Gabriele Pollara
1Division of Infection and Immunity, University College London, London, UK
Rishi K Gupta
2Institute for Global Health, University College London, London, UK
Jose Afonso Guerra-Assuncao
1Division of Infection and Immunity, University College London, London, UK
Annemarie Woolston
1Division of Infection and Immunity, University College London, London, UK
Tahel Ronel
1Division of Infection and Immunity, University College London, London, UK
Corrina Pade
3Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Joseph Gibbons
3Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Blanca Sanz-Magallon Duque De Estrada
1Division of Infection and Immunity, University College London, London, UK
Marc Robert de Massy
1Division of Infection and Immunity, University College London, London, UK
Matthew Whelan
1Division of Infection and Immunity, University College London, London, UK
Amanda Semper
4National Infection Service, Public Health England, Porton Down, UK
Tim Brooks
4National Infection Service, Public Health England, Porton Down, UK
Daniel M Altmann
5Department of Immunology and Inflammation, Imperial College London, London, UK
Rosemary J Boyton
6Department of Infectious Disease, Imperial College London, London, UK
7Lung Division, Royal Brompton Harefield Hospitals, London, UK
Áine McKnight
3Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Charlotte Manisty
8Institute of Cardiovascular Sciences, University College London, London, UK
Thomas Alexander Treibel
8Institute of Cardiovascular Sciences, University College London, London, UK
James Moon
8Institute of Cardiovascular Sciences, University College London, London, UK
Gillian S Tomlinson
1Division of Infection and Immunity, University College London, London, UK
Mala K Maini
1Division of Infection and Immunity, University College London, London, UK
Benjamin M Chain
1Division of Infection and Immunity, University College London, London, UK
Mahdad Noursadeghi
1Division of Infection and Immunity, University College London, London, UK
Posted March 31, 2021.
Non-severe SARS-CoV-2 infection is characterised by very early T cell proliferation independent of type 1 interferon responses and distinct from other acute respiratory viruses
Aneesh Chandran, Joshua Rosenheim, Gayathrie Nageswaran, Leo Swaddling, Gabriele Pollara, Rishi K Gupta, Jose Afonso Guerra-Assuncao, Annemarie Woolston, Tahel Ronel, Corrina Pade, Joseph Gibbons, Blanca Sanz-Magallon Duque De Estrada, Marc Robert de Massy, Matthew Whelan, Amanda Semper, Tim Brooks, Daniel M Altmann, Rosemary J Boyton, Áine McKnight, Charlotte Manisty, Thomas Alexander Treibel, James Moon, Gillian S Tomlinson, Mala K Maini, Benjamin M Chain, Mahdad Noursadeghi, COVIDsortium Investigators
medRxiv 2021.03.30.21254540; doi: https://doi.org/10.1101/2021.03.30.21254540
Non-severe SARS-CoV-2 infection is characterised by very early T cell proliferation independent of type 1 interferon responses and distinct from other acute respiratory viruses
Aneesh Chandran, Joshua Rosenheim, Gayathrie Nageswaran, Leo Swaddling, Gabriele Pollara, Rishi K Gupta, Jose Afonso Guerra-Assuncao, Annemarie Woolston, Tahel Ronel, Corrina Pade, Joseph Gibbons, Blanca Sanz-Magallon Duque De Estrada, Marc Robert de Massy, Matthew Whelan, Amanda Semper, Tim Brooks, Daniel M Altmann, Rosemary J Boyton, Áine McKnight, Charlotte Manisty, Thomas Alexander Treibel, James Moon, Gillian S Tomlinson, Mala K Maini, Benjamin M Chain, Mahdad Noursadeghi, COVIDsortium Investigators
medRxiv 2021.03.30.21254540; doi: https://doi.org/10.1101/2021.03.30.21254540
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (623)
- Anesthesia (162)
- Cardiovascular Medicine (2335)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11696)
- Forensic Medicine (10)
- Gastroenterology (693)
- Genetic and Genomic Medicine (3679)
- Geriatric Medicine (345)
- Health Economics (630)
- Health Informatics (2362)
- Health Policy (925)
- Hematology (339)
- HIV/AIDS (772)
- Medical Education (363)
- Medical Ethics (104)
- Nephrology (396)
- Neurology (3436)
- Nursing (194)
- Nutrition (519)
- Oncology (1800)
- Ophthalmology (533)
- Orthopedics (217)
- Otolaryngology (285)
- Pain Medicine (230)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1021)
- Primary Care Research (415)
- Public and Global Health (6084)
- Radiology and Imaging (1254)
- Respiratory Medicine (821)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (396)
- Toxicology (50)
- Transplantation (171)
- Urology (144)